修订后的费率是对医疗成本上升的回应，更近期的数据证明了相比早期提案的更大幅度增长是合理的。特朗普政府的决定表明其对Medicare Advantage（医疗保险优势计划）的强力支持，该计划中私人保险公司为联邦计划中的老年人和残障参与者管理福利。

Chief Financial Officer Thomas Cowhey is preparing to step down, according to a Bloomberg News report citing sources familiar ...

CVS Health (NYSE:CVS) finance chief Thomas Cowhey is set to step down amid the company's ongoing turnaround efforts led by ...

CVS Health (NYSE:CVS) has had a great run on the share market with its stock up by a significant 39% over the last three ...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said ...

The revised rate is a response to rising medical costs, with more recent data justifying the steeper increase compared to the earlier proposal. The Trump administration’s decision signals robust ...

We recently published a list of Jim Cramer Highlighted 12 Stocks and Tariff Panic. In this article, we are going to take a ...

CVS faces pressures from rising medical costs, but promising guidance, stable finances, and low valuations suggest strong ...

CVS Health Co. (NYSE:CVS – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twenty-one research firms that are covering the firm, MarketBeat reports. Three equities ...

One quarter into 2025, CVS Health has risen the most of any stock in the S&P 500, with a share price that has popped 50% ...

I rate CVS Health as a BUY due to its undervaluation and potential for financial growth despite current sector uncertainties. CVS's revenue is growing, but profitability is declining due to retail ...

CVS Health Corp. continues to fight a civil lawsuit that accuses the corporation and its retail pharmacists of wrongfully ...